Abstract
Sympatholytic drugs are agents that decrease the activity of the sympathetic nervous system (SNS). This is accomplished via a variety of mechanisms that most commonly include adrenergic receptor blockade (e.g., a and β adrenergic receptor antagonism) as well as specific receptor agonism (i.e., a2 adrenergic receptor agonism) (1). The SNS signal, however, may be blocked in other ways (e.g., peripheral ganglionic blockade) (2).
Original language | English (US) |
---|---|
Title of host publication | Pain Medicine |
Subtitle of host publication | An Essential Review |
Publisher | Springer International Publishing |
Pages | 193-195 |
Number of pages | 3 |
ISBN (Electronic) | 9783319431338 |
ISBN (Print) | 9783319431314 |
DOIs | |
State | Published - Jan 1 2017 |
Keywords
- Acute panic performance anxiety
- Adrenergic receptor antagonism
- Complex regional pain syndrome
- Drug interactions
- Migraine
- Nightmares
- Post-traumatic stress disorder
- Side effects
- Weaning
ASJC Scopus subject areas
- Medicine(all)